Alle Storys
Folgen
Keine Story von Intercell AG mehr verpassen.

Intercell AG

EANS-News: Report pursuant to Section 159 Para 3 and Para 2 lit 3 and Section 95 Para 6 of the Austrian Stock Corporation Act

Vienna, December 15, 2010 - (euro adhoc) -

  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
Company Information/Rep. purs. Sec. 159 para 3 and para 2 and section
95 para 6
Stock Option Program
Pursuant to Section 4.11 of the Articles of Association in accordance
with Section 159 Para 3 of the Stock Corporation Act the Management 
Board is authorized to increase the share capital until June 13, 2013
by up to a nominal amount of EUR 855,000.00 in one or several 
tranches to allocate stock options to employees, executive employees 
and members of the Management Board of the Company or its 
subsidiaries subject to the approval of the Supervisory Board 
(authorised conditional capital 2008).
On December 15, 2010, the Management Board has, in accordance with 
the aforementioned authorisation, passed the resolution to 
conditionally increase the share capital of the Company by EUR 
855,000 through the issuance of up to 855,000 new ordinary no-par 
value bearer shares with a nominal value of EUR 1.00 per share. The 
share capital shall be increased only to the extent that the 
beneficiary option holders to whom stock options were allocated 
actually exercise their subscription rights. The resolution of the 
Management Board has to be authorized by a resolution of the 
Supervisory Board. At least two weeks before the resolution of the 
Supervisory Board is passed, a report pursuant to Section 159 Para 3 
and Para 2 lit 3 of the Stock Corporation Act has to be published 
according to Section 82 Para 9 and Para 8 of the Austrian Stock 
Exchange Act. Publication pursuant to the Stock Exchange Act replaces
publication under the Law on Stock Corporations (Section 82 para 10 
Stock Exchange Act). Alternatively, options can be served through own
shares. The Management Board is, further, entitled to issue shares of
its own for the service of stock options and has decided to exercise 
this authority in the amount of 105,000 additional stock options; as 
a result, 960,000 stock options are to be granted in all. Because 
this means that options are to be issued that are (also) to be served
through own shares, the Management Board and Supervisory Board 
herewith file report under Section 159 para 2 lit 3 of the Stock 
Exchange Act and in accordance with Section 95 para 6 of the Stock 
Exchange Act.
Principles and incentives underlying the options
Trough the issuance of stock options, the motivation of the 
beneficiary option holders to contribute to the value creation of the
Company shall be increased.
Existing options and granting of options
Until now, the following numbers of stock options have been granted 
(excluding options that have been cancelled):
Beneficiaries                                 Numbers of options
Members of the Supervisory Board
  Michel Gréco(Chairman)                                  43,750
  Ernst Afting                                            51,250
  James R. Sulat                                          42,500
  David Ebsworth                                          45,000
  Hans Wigzell                                            45,000
Members of the Management Board
  Gerd Zettlmeissl (Chairman)                            473,500
  Thomas Lingelbach                                      350,000
  Reinhard Kandera                                       186,000
  Mustapha Leavenworth Bakali                             50,000
Executive employees                                      830,900
Other employees                                          221,525
Employees of subsidiaries                                731,342
Total                                                  3,070,767
Now, an additional number of 960,000 options shall be granted, 
thereof 90,000 to employees, 240,000 to executive employees, 230,000 
to employees of subsidiaries, 100,000 to the member of the Management
Board Gerd Zettlmeissl, 100.000 to the member of the Management Board
Thomas Lingelbach, 100.000 to the member of the Management Board 
Staph Bakali and 100.000 to the member of the Management Board 
Reinhard Kandera. As underlying shares to serve the exercise of these
options new shares from the above mentioned conditional capital shall
be used and partly also own shares of treasury stock may be used, 
therefore the report is also submitted according to Section 95 Para 6
Stock Corporation Act by the Management Board and by the Supervisory 
Board.
The number of stock options offered to each employee and executive 
employee are subject to a resolution of the Management Board 
according to the principles stated in the ESOP 2008. The allocation 
of stock options to the members of the Management Board is subject of
a resolution of the Supervisory Board.
Principle conditions of the stock option agreements
(i) Each beneficiary is entitled, subject to the detailed provisions 
of a stock options agreement, which includes the provisions of the 
ESOP 2008, and subject to the payment of the strike price to convert 
one option into one share. The strike price, i.e. the price which the
beneficiaries have to pay to the Company in order to exercise their 
options, shall be EUR 9.22 (the last closing price of the Intercell 
share prior to the publication of this report).
(ii) The exercise of the options is subject to the achievement of an 
exercise hurdle. The exercise hurdle is achieved if the closing price
of the Intercell share on the day prior to the start of an execution 
window is at least 15 percent above the strike price.
(iii) The term of the options is limited with the expiry of the 
execution window in the fifth year following the calendar year in 
which the options were granted. 25% of the options granted to the 
beneficiaries become exercisable in each of the second, the third, 
the fourth and the fifth year following the year in which the options
were granted. For options that are granted as special incentive, in 
particular in connection with the engagement of new executive members
the first exercise can be determined deviant. In case of a change of 
control through taking over of more than 50% of the proportion of the
voting rights of the Company all outstanding options are exercisable 
with the effectiveness of the take over. In any other case the 
options are only exercisable during an execution window.
(iv) The execution windows are periods of up to four weeks each, 
determined by the management board of the Company. An annual 
execution window starts the day after every annual ordinary 
shareholder´s meeting during the term of the options, in which the 
options may be exercised. The management board may determine an 
additional execution window per year. The time when an option becomes
first exercise will not be affected by this.
(v) The options are not transferable except for a transfer by death.
(vi) No lock-up period exists with respect to the shares received 
from exercising the options.
(vii) The ESOP 2008 is available at the Company´s head offices and 
may be inspected by every shareholder. Upon request, every 
shareholder shall receive a copy of the ESOP 2008 in a timely manner 
and free of charge.
Vienna, December 15, 2010
INTERCELL AG
Management Board
Supervisory Board
end of announcement                               euro adhoc

Further inquiry note:

Intercell AG
Gerald Strohmaier
Tel. +43 1 20620-1229
investors@intercell.com

Branche: Biotechnology
ISIN: AT0000612601
WKN: A0D8HW
Index: ATX Prime, ATX
Börsen: Wien / official market

Weitere Storys: Intercell AG
Weitere Storys: Intercell AG